Title : Polygenic risk score in post-mortem diagnosed sporadic early onset Alzheimer ’ s disease

Sporadic early onset Alzheimer’s disease (sEOAD) exhibits the symptoms of late onset Alzheimer’s disease (LOAD) but lacks the familial aspect of the early onset familial form. The genetics of Alzheimer’s disease (AD) identifies APOEε4 to be the greatest risk factor; however, it is a complex disease involving both environmental risk factors and multiple genetic loci. Polygenic risk scores (PRS) accumulate the total risk of a phenotype in an individual based on variants present in their genome. We determined whether sEOAD cases had a higher PRS compared to controls. A cohort of sEOAD cases were genotyped on the NeuroX array and PRS were generated using PRSice. The target dataset consisted of 408 sEOAD cases and 436 controls. The base dataset was collated by the IGAP consortium, with association data from 17,008 LOAD cases and 37,154 controls, which can be used for identifying sEOAD cases due to having shared phenotype. PRS were generated using all common SNPs between the base and target dataset, PRS were also generated using only SNPs within a 500kb region surrounding the APOE gene. Sex and number of APOE ε2 or ε4 alleles were used as variables for logistic regression and combined with PRS. The results show that PRS is higher on average in sEOAD cases than controls, although there is still overlap amongst the whole cohort. Predictive ability of identifying cases and controls using PRSice was calculated with 72.9% accuracy, greater than the APOE locus alone (65.2%). Predictive ability was further improved with logistic regression, identifying cases and controls with 75.5% accuracy.

[1]  Nick C Fox,et al.  Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease , 2017, Nature Genetics.

[2]  D. Hernandez,et al.  Mutation analysis of sporadic early-onset Alzheimer's disease using the NeuroX array , 2017, Neurobiology of Aging.

[3]  Gerard D. Schellenberg,et al.  Genomic variants, genes, and pathways of Alzheimer's disease: An overview , 2017, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[4]  J. Hardy,et al.  Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease , 2017, Neurobiology of Aging.

[5]  R. Sims,et al.  The Correlation between Inflammatory Biomarkers and Polygenic Risk Score in Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.

[6]  Lilah M. Besser,et al.  Personalized genetic assessment of age associated Alzheimer’s disease risk , 2016, bioRxiv.

[7]  M. Glymour,et al.  Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up , 2016, Alzheimer disease and associated disorders.

[8]  K. Hao,et al.  A loss of function variant in CASP7 protects against Alzheimer’s disease in homozygous APOE ε4 allele carriers , 2016, BMC Genomics.

[9]  Mohan Giri,et al.  Genes associated with Alzheimer’s disease: an overview and current status , 2016, Clinical interventions in aging.

[10]  Theresa M. Harrison,et al.  An Alzheimer’s Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults , 2016, eNeuro.

[11]  Amelia A. Assareh,et al.  The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume , 2016, Neurobiology of Aging.

[12]  M. Gill,et al.  Common polygenic variation enhances risk prediction for Alzheimer's disease. , 2015, Brain : a journal of neurology.

[13]  P. Deyn,et al.  A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42 , 2015, Alzheimer's & Dementia.

[14]  Jianfeng Xu,et al.  Risk prediction for sporadic Alzheimer's disease using genetic risk score in the Han Chinese population , 2015, Oncotarget.

[15]  A. Hofman,et al.  Genetic risk of neurodegenerative diseases is associated with mild cognitive impairment and conversion to dementia , 2015, Alzheimer's & Dementia.

[16]  M. Prince,et al.  World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends , 2015 .

[17]  Wei Pan,et al.  Testing for Polygenic Effects in Genome‐Wide Association Studies , 2015, Genetic epidemiology.

[18]  B. Miller,et al.  Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer’s disease , 2015, BMC Neurology.

[19]  Nicholas Eriksson,et al.  NeuroX, a fast and efficient genotyping platform for investigation of neurodegenerative diseases , 2015, Neurobiology of Aging.

[20]  Jack Euesden,et al.  PRSice: Polygenic Risk Score software , 2014, Bioinform..

[21]  T. Lehtimäki,et al.  Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach. , 2014, Journal of Alzheimer's disease : JAD.

[22]  K. Lunetta,et al.  Two rare AKAP9 variants are associated with Alzheimer's disease in African Americans , 2014, Alzheimer's & Dementia.

[23]  M. Glymour,et al.  Validation of a polygenic risk score for dementia in black and white individuals , 2014, Brain and behavior.

[24]  M. Nöthen,et al.  Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene , 2014, Translational Psychiatry.

[25]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[26]  Nick C Fox,et al.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease , 2013, Nature Genetics.

[27]  Benjamin F. J. Verhaaren,et al.  Alzheimer's Disease Genes and Cognition in the Nondemented General Population , 2013, Biological Psychiatry.

[28]  A. Hofman,et al.  Variant of TREM2 associated with the risk of Alzheimer's disease. , 2013, The New England journal of medicine.

[29]  N. Kowall,et al.  The Handbook Of Alzheimer's Disease And Other Dementias (Softcover) , 2013 .

[30]  O. Combarros,et al.  Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease , 2013, Journal of Neural Transmission.

[31]  S. Leng,et al.  Softwares and methods for estimating genetic ancestry in human populations , 2013, Human Genomics.

[32]  Jason H. Moore,et al.  Chapter 11: Genome-Wide Association Studies , 2012, PLoS Comput. Biol..

[33]  R. Buckner,et al.  The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. , 2012, Cerebral cortex.

[34]  D. Cutler,et al.  Autosomal recessive causes likely in early-onset Alzheimer disease. , 2012, Archives of neurology.

[35]  Wei Pan,et al.  Multilocus association testing with penalized regression , 2011, Genetic epidemiology.

[36]  John Whittaker,et al.  Analysis of multiple SNPs in a candidate gene or region , 2008, Genetic epidemiology.

[37]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[38]  Terrence S. Furey,et al.  The UCSC Table Browser data retrieval tool , 2004, Nucleic Acids Res..

[39]  S. Wilton,et al.  Apolipoprotein E and Alzheimer's disease , 1995 .

[40]  J. Mattick,et al.  Genome research , 1990, Nature.

[41]  Jan Bures,et al.  Neurobiology of Aging , 1975, Advances in Behavioral Biology.